Evotec (NASDAQ:EVO) Shares Gap Down – Here’s What Happened

Shares of Evotec SE (NASDAQ:EVO) gapped down before the market opened on Wednesday . The stock had previously closed at $3.64, but opened at $3.54. Evotec shares last traded at $3.55, with a volume of 4,948 shares.

Evotec Price Performance

The stock has a 50-day simple moving average of $4.19 and a 200-day simple moving average of $4.10. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.09 and a quick ratio of 1.99.

Hedge Funds Weigh In On Evotec

Several hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP raised its holdings in shares of Evotec by 29.7% in the 3rd quarter. Wellington Management Group LLP now owns 2,634,434 shares of the company’s stock valued at $9,616,000 after acquiring an additional 602,858 shares in the last quarter. DCF Advisers LLC lifted its position in Evotec by 5.9% during the fourth quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock valued at $956,000 after purchasing an additional 12,816 shares during the last quarter. BNP Paribas Financial Markets purchased a new position in Evotec in the 4th quarter worth approximately $27,000. Bank of America Corp DE increased its holdings in shares of Evotec by 262.5% in the 4th quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock worth $53,000 after buying an additional 9,289 shares during the last quarter. Finally, Lighthouse Investment Partners LLC purchased a new stake in shares of Evotec during the 4th quarter valued at $166,000. 5.81% of the stock is currently owned by hedge funds and other institutional investors.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.